Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-01-02

FDA Approved: ZOLPIDEM TARTRATE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

The FDA approved a supplemental application for zolpidem tartrate filed by Sandoz Inc., authorizing changes to an existing zolpidem tartrate product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zolpidem Tartrate (zolpidem tartrate)

Snippet

SUPPL AP for ZOLPIDEM TARTRATE (ZOLPIDEM TARTRATE)